{"id":"https://openalex.org/W3028642376","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps1113","title":"Phase II trial of a PARP inhibitor in somatic BRCA mutant metastatic breast cancer.","display_name":"Phase II trial of a PARP inhibitor in somatic BRCA mutant metastatic breast cancer.","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3028642376","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps1113","mag":"3028642376"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.tps1113","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps1113","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps1113","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039802529","display_name":"Neelima Vidula","orcid":"https://orcid.org/0000-0002-5963-7052","observed_orcids":["https://orcid.org/0000-0002-5963-7052"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neelima Vidula","raw_affiliation_strings":["Massachusetts General Hospital, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, San Francisco, CA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073757407","display_name":"Nora Horick","orcid":"https://orcid.org/0000-0002-4355-5853","observed_orcids":["https://orcid.org/0000-0002-4355-5853"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nora K. Horick","raw_affiliation_strings":["Massachusetts General Hospital Biostatistics Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Biostatistics Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062180181","display_name":"Erica L. Blouch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erica Blouch","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074171640","display_name":"Amalia Rivera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amalia Rivera","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037793164","display_name":"Erin Basile","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Basile","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072970079","display_name":"Ruth Fax","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruth Fax","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052735318","display_name":"Leif William Ellisen","orcid":"https://orcid.org/0000-0003-0444-7910","observed_orcids":["https://orcid.org/0000-0003-0444-7910"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leif W. Ellisen","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090188675","display_name":"Hope S. Rugo","orcid":"https://orcid.org/0000-0001-6710-4814","observed_orcids":["https://orcid.org/0000-0001-6710-4814"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hope S. Rugo","raw_affiliation_strings":["University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034972183","display_name":"Aditya Bardia","orcid":"https://orcid.org/0000-0003-4885-1157","observed_orcids":["https://orcid.org/0000-0003-4885-1157"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditya Bardia","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"TPS1113","last_page":"TPS1113"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.9039999842643738},{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9929999709129333},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cell-free-dna","display_name":"cell-free DNA","score":0.8730000257492065},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.75},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.8989999890327454},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9539999961853027},{"id":"https://openalex.org/keywords/genome-evolution","display_name":"genome evolution","score":0.7689999938011169},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8285319209098816},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.7478213906288147},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6848443746566772},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.629827082157135},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5760504007339478},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5546577572822571},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.5353034138679504},{"id":"https://openalex.org/C2780194787","wikidata":"https://www.wikidata.org/wiki/Q4836333","display_name":"BRCA mutation","level":4,"score":0.49126094579696655},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.47517672181129456},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4536170959472656},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4308398962020874},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.4275110960006714},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36964547634124756},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.1968599557876587},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.10562890768051147},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09271043539047241},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07637852430343628},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.tps1113","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps1113","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps1113","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3170454691","https://openalex.org/W4379328288","https://openalex.org/W4399349506","https://openalex.org/W4411285981","https://openalex.org/W4322774055","https://openalex.org/W4396587286","https://openalex.org/W3129303686","https://openalex.org/W4220958205","https://openalex.org/W3011175332","https://openalex.org/W2787300557"],"abstract_inverted_index":{"TPS1113":[0],"Background:":[1],"Poly(ADP-ribose)":[2],"polymerase":[3],"(PARP)":[4],"inhibitors":[5],"are":[6,220],"now":[7],"approved":[8],"for":[9,27,142],"patients":[10,104,245,292],"with":[11,105,119,135,172,185,236],"germline":[12,22,79,165],"BRCA1/2":[13,23,43,57,108,166,267],"mutated":[14],"HER2":[15,132],"negative":[16,133],"metastatic":[17],"breast":[18,30],"cancer":[19],"(MBC).":[20],"However,":[21],"mutations":[24,44],"only":[25],"account":[26],"5-10%":[28],"of":[29,38,97,121,154,183,275,282,300],"cancer.":[31],"We":[32,53],"previously":[33],"demonstrated":[34],"that":[35,55,232,309],"a":[36,99,148,163,223],"subset":[37],"MBC":[39,59,110],"may":[40,60,115,145,303],"harbor":[41],"somatic":[42,56,77,106],"detectable":[45],"by":[46,112,216],"cell-free":[47],"DNA":[48],"(cfDNA)":[49],"(Vidula,":[50],"SABCS,":[51],"2017).":[52,82],"hypothesize":[54],"mutant":[58,109,268],"also":[61],"respond":[62],"to":[63,67,230,312],"PARP":[64,71,100,315],"inhibition,":[65],"similar":[66],"ovarian":[68],"cancer,":[69],"where":[70],"inhibition":[72],"is":[73,93,211,234,289,310],"efficacious":[74],"in":[75,102,151,222,242,266],"both":[76],"and":[78,193,195,203,254,279],"tumors":[80],"(Oza,":[81],"Methods:":[83],"This":[84,287],"single":[85],"arm,":[86],"open":[87],"label,":[88],"phase":[89],"II":[90],"clinical":[91,186],"trial":[92,288,318],"evaluating":[94],"the":[95,152,280,294,306],"efficacy":[96],"talazoparib,":[98],"inhibitor,":[101],"30":[103],"pathogenic":[107],"identified":[111],"cfDNA.":[113],"Patients":[114,144,159,168],"have":[116,146,162],"triple-negative":[117],"disease":[118,134],"receipt":[120],"at":[122,136,293],"least":[123,137],"1":[124,138,174],"prior":[125,139,149],"chemotherapy":[126],"regimen,":[127],"or":[128,181],"hormone":[129,140],"receptor":[130],"positive,":[131],"therapy":[141],"MBC.":[143],"received":[147],"platinum,":[150],"absence":[153],"progression":[155],"on":[156,285],"platinum":[157],"chemotherapy.":[158],"must":[160],"not":[161],"known":[164],"mutation.":[167],"will":[169],"be":[170],"treated":[171],"talazoparib":[173],"mg":[175],"daily":[176],"until":[177],"progression,":[178],"unacceptable":[179],"toxicity,":[180],"withdrawal":[182],"consent,":[184],"exams":[187],"monthly,":[188],"scans":[189],"(CT":[190],"chest,":[191],"abdomen,":[192],"pelvis,":[194],"bone":[196],"scan":[197],"as":[198,214],"appropriate)":[199],"every":[200],"3":[201],"months,":[202],"serial":[204],"cfDNA":[205],"collected":[206],"monthly.":[207],"The":[208],"primary":[209],"endpoint":[210],"progression-free":[212],"survival,":[213],"defined":[215],"RECIST":[217],"1.1.":[218],"Subjects":[219],"enrolled":[221],"2-stage":[224],"design,":[225],"which":[226],"provides":[227],"80%":[228],"power":[229],"demonstrate":[231],"treatment":[233],"associated":[235],"\u201csuccess\u201d":[237],"(PFS":[238],">":[239],"12":[240],"weeks)":[241],"\u00b3":[243],"53%":[244],"(4%":[246],"alpha).":[247],"Additional":[248],"endpoints":[249,262],"include":[250,263],"objective":[251],"response":[252],"rate":[253],"toxicity":[255],"(per":[256],"NCI":[257],"CTCAE":[258],"version":[259],"5.0).":[260],"Correlative":[261],"determining":[264],"changes":[265,284],"allele":[269],"fraction,":[270],"genomic":[271],"evolution":[272],"including":[273],"emergence":[274],"BRCA":[276],"reversion":[277],"mutations,":[278],"impact":[281],"biomarker":[283],"outcomes.":[286],"currently":[290],"enrolling":[291],"Massachusetts":[295],"General":[296],"Hospital.":[297],"Successful":[298],"completion":[299],"this":[301],"study":[302],"help":[304],"expand":[305],"patient":[307],"population":[308],"able":[311],"benefit":[313],"from":[314],"inhibition.":[316],"Clinical":[317],"information:":[319],"NCT03990896":[320],".":[321]},"counts_by_year":[{"year":2022,"cited_by_count":2}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-06-05T00:00:00"}